Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Neurosteroids show promise for treating epilepsy and more research is needed.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hair loss requires customized treatments based on its various causes and types.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Moderately high prolactin levels do not cause hair loss in women.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Lower ghrelin levels and certain gene variations may increase acne risk.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Obese and lean women with PCOS have different symptoms and need different treatments.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.